News

June 11, 2018

EA Pharma licenses rights to AJT-240 in China to Tasly Pharmaceutical
PRESS RELEASE  |  DEAL ALERT

June 7, 2018

Onxeo S.A. Secures $7.5 Million of Non-Dilutive Capital from SWK Holdings Corporation Through the Partial Sale of Future Beleodaq® Royalties
PRESS RELEASE  |  DEAL ALERT

May 23, 2018

Epigen Biosciences Licenses its LPA1 Receptor small molecule program to Novo Nordisk
PRESS RELEASE  |  DEAL ALERT

April 26, 2018

Somerset Therapeutics and Affiliate Wintac, Limited to be Acquired by Endo
PRESS RELEASE  |  DEAL ALERT

March 30, 2018

pSivida Acquires Icon Bioscience, Rebrands as EyePoint Pharmaceuticals, and Raises both Equity and Debt Capital
PRESS RELEASE  |  DEAL ALERT

January 19, 2018

Bio-Pharm Acquired by Torrent Pharma
PRESS RELEASE  |  DEAL ALERT

December 18, 2017

Neuland Laboratories Completes Acquisition of API Facility from Arch Pharmalabs
PRESS RELEASE  |  DEAL ALERT

November 17, 2017

Cerecor Acquires TRx Pharmaceuticals
PRESS RELEASE  |  DEAL ALERT

November 15, 2017

CombiMatrix Successfully Completes Transformation Merger with Invitae
PRESS RELEASE  |  DEAL ALERT

November 14, 2017

Crown Laboratories to Sell Major Stake to Hildred Capital Partners
PRESS RELEASE  |  DEAL ALERT

October 24, 2017

Torreya’s in-depth study of the future of the pharmaceutical industry reveals the sector is larger and faster-growing than previously thought.
VIEW MORE

July 27, 2017

Update on Torreya’s recent activity advising on M&A, capital markets, and licensing transactions
VIEW MORE

July 26, 2017

Accord Healthcare Announces Acquisition of Essential Pharmaceuticals
PRESS RELEASE  |  DEAL ALERT

June 14, 2017

JSR Life Sciences Agrees to Acquire Pioneering Cell Line Developer Selexis SA and Integrate Selexis with KBI Biopharma, Inc.
PRESS RELEASE  |  DEAL ALERT

April 20, 2017

Japan’s Sawai Pharmaceutical to Acquire the Generics Business of U.S. Upsher‐Smith Laboratories
PRESS RELEASE  |  DEAL ALERT

January 30, 2017

Mallinckrodt To Sell Intrathecal Therapy Business To Piramal Enterprises Limited For Approximately $203 Million
PRESS RELEASE  |  DEAL ALERT

December 21, 2016

XOMA Announces up to $22 Million Generated from Sale of Royalty Streams from Two License Agreements to HealthCare Royalty Partners and Provides Corporate Update
PRESS RELEASE

December 15, 2016

Opiant Pharmaceuticals, Inc. Announces NARCAN Nasal Spray Royalty Monetization
PRESS RELEASE

October 25, 2016

Everstone Capital Invests Rs 220 Crore in Rubicon Research
PRESS RELEASE

August 5, 2016

IntelGenx Announces Sale of Forfivo XL(R) Royalty for $6 Million
PRESS RELEASE

July 11, 2016

New Mountain Capital Partners with Topix Pharmaceuticals
PRESS RELEASE

May 13, 2016

WaferGen Bio-systems and Takara Bio Inc. Announce Merger Agreement
PRESS RELEASE  |  DEAL ALERT

February 29, 2016

Hikma Announces the Close of the Roxane Laboratories Acquisition
PRESS RELEASE

February 1, 2016

ANI Pharmaceuticals Acquires Exclusive Rights to Distribute Three Generic Drug Products from H2-Pharma for $10 Million
PRESS RELEASE

December 23, 2015

Agenus Acquires PhosImmune with a Novel Class of Cancer Neoantigens
PRESS RELEASE

November 17, 2015

Pharma Industry Veterans Launch Vertice Pharma in Partnership with Warburg Pincus; Announce Acquisition of VistaPharm
PRESS RELEASE

November 5, 2015

XOMA Announces the Sale of Its Manufacturing Facilities to Agenus
PRESS RELEASE

November 5, 2015

XOMA divests biodefense program to Nanotherapeutics, Inc.
PRESS RELEASE

October 13, 2015

IGI Laboratories, Inc. Enters Into Agreement To Acquire The Assets Of Canadian Pharmaceutical Company, Alveda Pharmaceuticals, Inc.
PRESS RELEASE

October 1, 2015

XOMA Announces Development and Commercialization Agreement for First-in-Class Anti-TGF-beta Antibody Program in Immuno-Oncology
PRESS RELEASE

July 28, 2015

Merck Enhances Immuno-Oncology Portfolio with Acquisition of cCAM Biotherapeutics
PRESS RELEASE

July 13, 2015

ANI Pharmaceuticals Acquires 22 Generic Drug Products from Teva Pharmaceuticals for $25 million
PRESS RELEASE

June 9, 2015

Mission Pharmacal Acquires ProSolus Pharmaceuticals
PRESS RELEASE

June 4, 2015

DARA BioSciences (DARA), Midatech Pharma Enter Merger Agreement
PRESS RELEASE

May 21, 2015

arGEN-X and LEO Pharma Enter into Alliance to Develop Antibody-based Treatments for Skin Conditions
PRESS RELEASE

May 19, 2015

Ipsen strengthens its presence in the oncology field with the acquisition of OctreoPharm Sciences, a company developing innovative radiopharmaceuticals for the diagnosis and treatment of neuroendocrine tumours
PRESS RELEASE

March 18, 2015

Prestium Pharma, Inc. Acquires ZONALON® (Doxepin Hydrochloride), 5% Cream; Continues to Expand its Product Portfolio
PRESS RELEASE

March 5, 2015

TRIANEX® 0.05%(Triamcinolone Acetonide Ointment,USP) Now Available from Promius Pharma, LLC
PRESS RELEASE

January 6, 2015

Gilead Sciences Announces Acquisition of Phenex Pharmaceuticals’ Development Program for Non-Alcoholic Steatohepatitis (NASH) and Other Liver Diseases
PRESS RELEASE

December 16, 2014

Lightlake Therapeutics Inc. Announces Licensing Deal With Adapt Pharma Limited Subsidiary
PRESS RELEASE

December 15, 2014

Aseptix signs global technology license with Ecolab
PRESS RELEASE

November 24, 2014

Flamel Technologies Sells Development and Manufacturing Facility in Pessac, France to Recipharm AB
PRESS RELEASE

November 3, 2014

PDI Expands Molecular Diagnostics Business with RedPath Integrated Pathology Acquisition
PRESS RELEASE

October 23, 2014

Probiodrug raises €22.5 million in successful Initial Public Offering and listing on Euronext Amsterdam
PRESS RELEASE

October 23, 2014

Medivation Inc. Licenses Clinical Stage Anti-PD-1 Immune Modulatory Monoclonal Antibody From CureTech Ltd. for Potential Applications in Oncology
PRESS RELEASE

October 22, 2014

DBV Technologies S.A. Announces Pricing of Global Offering
PRESS RELEASE

October 16, 2014

Molecular Imaging Firm Raises $15M for Global Expansion
PRESS RELEASE

July 30, 2014

First Generation Capital to maintain 23.7% Trimel ownership following new financing
PRESS RELEASE

July 17, 2014

Trimel Pharmaceuticals Acquires Canadian Rights to Estrace®
PRESS RELEASE

May 19, 2014

Ventrus Biosciences to Merge With Assembly Pharmaceuticals
PRESS RELEASE

May 8, 2014

Lundbeck to acquire Chelsea Therapeutics
PRESS RELEASE

May 2, 2014

Shire Acquires Fibrotech For US$75 Million
PRESS RELEASE

March 20, 2014

Concordia Healthcare Announces Agreement to Acquire Donnatal
PRESS RELEASE

February 28, 2014

Compugen Ltd. Prices Public Offering of Ordinary Shares
PRESS RELEASE

February 20, 2014

DenMat, the Makers of Lumineers, Acquires Substantially All Dental Assets of Zila, Inc.
PRESS RELEASE

February 19, 2014

Torreya Partners Announces Three Executive Promotions
PRESS RELEASE

November 25, 2013

Genomic Health and Almac Group Enter Exclusive In-Licensing Agreement to Develop and Commercialize Anthracycline Chemotherapy Benefit Test for High Risk Breast Cancer
PRESS RELEASE

November 18, 2013

Cardiome to Acquire Correvio LLC
PRESS RELEASE

November 14, 2013

DBV Technologies announces the completion of a €29.9m private placement with a majority placed with US investors
PRESS RELEASE

September 30, 2013

Stratus Media Group Enters Dermatological and Restorative Medicine Industry, Signs Merger Agreement With Two Biopharmaceutical Companies, Changes Corporate Name To Restorgenex Corporation, and Announces New Chairman and Vice Chairman
PRESS RELEASE

August 20, 2013

PDI, Inc. Enters into Collaboration Agreement to Commercialize Molecular Diagnostic Tests
PRESS RELEASE

August 5, 2013

Bayer Enters Cancer Research Deal with Compugen
PRESS RELEASE

July 18, 2013

Bausch + Lomb Acquires Option to License New Compound to Treat Dry Eye Syndrome (DES)
PRESS RELEASE

May 7, 2013

SHIONOGI INC. DIVESTS AND EXCLUSIVELY LICENSES ITS PEDIATRIC PRODUCTS TO CONCORDIA PHARMACEUTICALS INC.
PRESS RELEASE

April 30, 2013

Selexis SA Sells Rights to Royalty Payments for More Than 15 Biologic Development Programs to Ligand Pharmaceuticals
PRESS RELEASE

March 11, 2013

CLINIGEN Clinigen Group and Theravance Entered into Exclusive Commercialization Agreement in the EU for Antibacterial VIBATIV
PRESS RELEASE

January 22, 2013

Progenics Acquires Molecular Insight Pharmaceuticals to Expand Oncology-Focused Pipeline
PRESS RELEASE

October 1, 2012

ProStrakan Acquires Breast Cancer Product for the US
PRESS RELEASE

August 27, 2012

Merz, Inc. Announces the Acquisition of CUVPOSA® (glycopyrrolate) Oral Solution, First and Only FDA-Approved Treatment for Pediatric Chronic Severe Drooling Associated With Neurologic Conditions
PRESS RELEASE

June 21, 2012

Depomed Announces Acquisition Of Zipsor® (diclofenac potassium) From Xanodyne Pharmaceuticals, Inc.
PRESS RELEASE

July 15, 2011

NeoStem to acquire Amorcyte
PRESS RELEASE

May 27, 2011

PHARMASCIENCE ACQUIRES AEGERA THERAPEUTICS
PRESS RELEASE

April 4, 2011

Royalty Pharma Acquires Lexiscan® and Cubicin® Royalties for $487 Million
PRESS RELEASE

December 20, 2010

Lpath Grants Pfizer Exclusive Option for Worldwide License for iSONEP
PRESS RELEASE

October 25, 2010

Kadmon Pharmaceuticals Acquires Three Rivers Pharmaceuticals
PRESS RELEASE

July 30, 2010

Actient Pharmaceuticals, LLC Closes Transaction to License and Acquire Specialty Pharmaceutical Products from UCB, INC.
PRESS RELEASE

July 2, 2010

Watson Completes Acquisition of CRINONE(R) and PROCHIEVE(R) Product Line and Shares of Columbia Laboratories
PRESS RELEASE

July 1, 2010

Euthymics Bioscience, Inc. and DOV Pharmaceutical, Inc. Announce Merger Agreement
PRESS RELEASE

June 23, 2010

Thorne Research Announces Combination with Diversified Natural Products
PRESS RELEASE